The overall detection of high levels of global histone acetylation was significantly associated with luminal-like breast tumors, whereas moderate to low global lysine acetylation was linked to basal carcinoma and HER2-positive tumors [65]. This evidence concerns the gene ERBB2 and breast neoplasm.